Ieq Capital LLC Invests $1.25 Million in HCA Healthcare, Inc. $HCA

Key Points

• Ieq Capital acquired 3,216 HCA Healthcare shares worth approximately $1.25 million during the second quarter. Institutional investors and hedge funds collectively own 62.73% of HCA’s outstanding stock.
• HCA reported quarterly revenue of $20.23 billion, up 8.7% year over year, and earnings of $7.59 per share, slightly exceeding analyst expectations.
• The company declared a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 payout and a 0.7% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $462.64.

Ieq Capital LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,216 shares of the company's stock, valued at approximately $1,254,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. bought a new stake in shares of HCA Healthcare in the second quarter worth $5,069,974,000. State Street Corp grew its holdings in shares of HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company's stock valued at $3,532,563,000 after acquiring an additional 76,039 shares in the last quarter. Capital World Investors increased its position in shares of HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company's stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock valued at $1,702,738,000 after buying an additional 13,565 shares in the last quarter. Finally, Norges Bank bought a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Down 0.6%

HCA opened at $426.36 on Thursday. The company has a 50-day simple moving average of $399.36 and a 200 day simple moving average of $442.21. The stock has a market capitalization of $92.31 billion, a price-to-earnings ratio of 14.27, a P/E/G ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the firm earned $6.84 earnings per share. The business's quarterly revenue was up 8.7% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is 10.45%.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lowered their price target on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a research report on Thursday, August 20th. Truist Financial reduced their target price on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Mizuho cut their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a research note on Tuesday, July 28th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and an average price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source